US FDA approves Regeneron’s 8-mg dose of eye disease drug Eylea

(Reuters) – The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron Pharmaceuticals’ eye disease drug Eylea, the company said in a statement on Friday.

(Reporting by Jahnavi Nidumolu in Bengaluru; Editing by Sandra Maler)